FDA approves Regeneron drug for generalized myasthenia gravisThe FDA approved Regeneron Pharmaceuticals' drug to treat adults with generalized myasthenia gravis, a rare autoimmune disease.Nov 18, 2026·4 sourcesFDA drug approvalRisk evaluation & mitigation (REMS)Drug Policy, Pricing & ApprovalClinical trialsRare diseasesAutoimmune diseaseEuropean Union00